Strados Labs, the respiratory endpoint intelligence company, announces the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados’ suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) – complementing its existing technologies for cough monitoring and lung sound monitoring to create a unique end-to-end offering for Phase I through Phase IV respiratory trials.
Read the full article: Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/strados-labs-acquires-clinical-trial-business-of-nuvoair-delivering-f-1158225